Flexible IRT Solution To Support New And Complex Trial Designs

New and more complex clinical studies—like master protocol studies that use a single infrastructure, trial design, and protocol to simultaneously evaluate multiple drugs and/or disease populations in multiple substudies—help the industry accelerate development and approval of novel therapies to address unmet needs. Read how these new trial designs keep clinical supply and operations teams busier than ever managing multiple therapies across multiple indications, sometimes in partnership with multiple sponsors.